Inhibitors of cyclophilins and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8802666
APP PUB NO 20130018044A1
SERIAL NO

13517148

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75016 PARIS
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC CEDEX 13 PARIS 75013
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS3 AVENUE VICTORIA PARIS 75004
UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE61 AVENUE DU GENERAL DE GAULLE CRETEIL F-94010
UNIVERSITE MONTPELLIER 15 BOULEVARD HENRI IV 34000 MONTPELLIER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahmed-Belkacem, Hakim Creteil, FR 2 0
Colliandre, Lionel Orleans Cedex 2, FR 2 0
Guichou, Jean-Francois Montpellier, FR 3 0
Pawlotsky, Jean-Michel Creteil, FR 5 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 12, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00